# Luspatercept (Genetical Recombination) for S.C. Injection 75mg (レブロジル皮下注用７５ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 3399417D2022). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 3399417D2022
- **Product name (Japanese):** レブロジル皮下注用７５ｍｇ
- **English title:** Luspatercept (Genetical Recombination) for S.C. Injection 75mg
- **Active ingredient:** ルスパテルセプト（遺伝子組換え）
- **Active ingredient (INN):** Luspatercept (Genetical Recombination)
- **Strength / unit:** ７５ｍｇ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 33 Blood and body fluid agents (血液・体液用薬) › 339 Other blood and body fluid agents (その他の血液・体液用薬)
- **Manufacturer:** Bristol Myers Squibb (ブリストル・マイヤーズ スクイブ)
- **NHI price (reference only):** JPY 505267 per ７５ｍｇ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/3399417D2022
- **JSON:** https://www.nifujipharma.com/api/drugs/3399417D2022

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Luspatercept%20(Genetical%20Recombination)%20for%20S.C.%20Injection%2075mg%20(%E3%83%AC%E3%83%96%E3%83%AD%E3%82%B8%E3%83%AB%E7%9A%AE%E4%B8%8B%E6%B3%A8%E7%94%A8%EF%BC%97%EF%BC%95%EF%BD%8D%EF%BD%87)%20%2F%20YJ%203399417D2022#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Luspatercept (Genetical Recombination)

- [Luspatercept (Genetical Recombination) for S.C. Injection 25mg (レブロジル皮下注用２５ｍｇ)](https://www.nifujipharma.com/drugs/3399417D1026) — ２５ｍｇ１瓶, Bristol Myers Squibb